The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for M V S Prasad Reddy
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
M V S Prasad Reddy, a promoter of Oxygenta Pharmaceutical Ltd, has filed a disclosure under SEBI SAST Regulations regarding a major reduction in his shareholding. Before the transaction, he held 94,52,902 shares (25.56% of the company). Through a Share Purchase Agreement dated 30th September 2024, he sold 77,52,902 shares (20.96% of the capital) on June 03, 2025. After the sale, his holding stands at just 17,00,302 shares (4.60%). The company's total equity remains unchanged at 3,69,83,500 shares of Rs. 10 each.
This is a significant promoter exit — the promoter's stake has dropped from a substantial 25.56% to a minority 4.60%, which could weaken promoter control and may signal a change in ownership dynamics. Retail investors should note the potential impact on management stability and monitor any further disclosures regarding the buyer's identity.